Bristol-Myers (BMY) option implied volatility flat, to present immuno-oncology-based research at ASCO

Bristol-Myers Squibb (NYSE: BMY) May call option implied volatility is at 33, June is at 25; compared to its 52-week range of 18 to 48 into announcing that data from over 70 company-sponsored studies and collaborations evaluating its oncology compounds across more than 20 types of cancer will be featured at the American Society of Clinical Oncology, or ASCO.

You May Also Be Interested In

• Netflix (NFLX) call put ratio 1.1 calls to 1 put into quarter results
• Elevance Health (ELV) April and May options active as share price up 4%
• Paramount Global (PARA) option IV near upper end of range